Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy: A Breast International Group (BIG) 1-98 sub-analyses.

被引：0
|
作者：
Leone, Jose Pablo
Cole, Bernard F.
Regan, Meredith M.
Thurlimann, Beat J. K.
Coates, Alan S.
Goldhirsch, Aron
Di Leo, Angelo
Colleoni, Marco
Luis, Ines Maria Vaz Duarte
Lin, Nancy U.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Vermont, Burlington, VT USA
[3] Dana Farber Harvard Canc Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA
[4] Kantonsspital, St Gallen, Switzerland
[5] Univ Sydney, Sydney, NSW, Australia
[6] IBCSG Investigator, Bern, Switzerland
[7] SOLE Investigator, Bern, Switzerland
[8] Hosp Prato, Prato, Italy
[9] European Inst Oncol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
538
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian, Li
    Xu, Feng-Rui
    Jiang, Ze-Fei
    CHINESE MEDICAL JOURNAL, 2020, 133 (19) : 2338 - 2345
  • [42] American Society of Clinical Oncology Clinical Practice Guideline Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
    Burstein, Harold J.
    Griggs, Jennifer J.
    Prestrud, Ann A.
    Temin, Sarah
    JOURNAL OF ONCOLOGY PRACTICE, 2010, 6 (05) : 243 - 246
  • [43] Updates on Adjuvant Therapy for Early Stage Hormone Receptor-Positive Breast Cancer
    Cavalcante, Ludimila L.
    Santa-Maria, Cesar A.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (12) : 18 - 23
  • [44] Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
    Johnston, Stephen R. D.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 89 - 102
  • [45] Weakly hormone receptor-positive breast cancer and use of adjuvant hormonal therapy
    Lin, Cassandra M.
    Jaswal, Jasbir
    Vandenberg, Theodore
    Tuck, Alan
    Brackstone, Muriel
    CURRENT ONCOLOGY, 2013, 20 (06) : E612 - E613
  • [46] EXTENDED ADJUVANT ENDOCRINE THERAPY IN HORMONE-RECEPTOR POSITIVE BREAST CANCER
    Goss, P. E.
    Badovinac-Crnjevic, T.
    Fan, L.
    BREAST, 2013, 22 : S18 - S18
  • [47] Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer
    Strasser-Weippl, Kathrin
    Badovinac-Crnjevic, Tanja
    Fan, Lei
    Goss, Paul E.
    BREAST, 2013, 22 : S171 - S175
  • [48] Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial
    Ewertz, Marianne
    Gray, Kathryn P.
    Regan, Meredith M.
    Ejlertsen, Bent
    Price, Karen N.
    Thuerlimann, Beat
    Bonnefoi, Herve
    Forbes, John F.
    Paridaens, Robert J.
    Rabaglio, Manuela
    Gelber, Richard D.
    Colleoni, Marco
    Lang, Istvan
    Smith, Ian E.
    Coates, Alan S.
    Goldhirsch, Aron
    Mouridsen, Henning T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) : 3967 - 3975
  • [49] The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor-Positive Breast Cancer COMMENT
    Lohmann, Ana Elisa
    Ennis, Marguerite
    Parulekar, Wendy R.
    Chen, Bingshu E.
    Tomlinson, George
    Goodwin, Pamela J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (07): : 924 - 929
  • [50] Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients
    Crystal, Jessica S.
    Rand, Jamie
    Johnson, Jeffrey
    Kim, Sungjin
    Basho, Reva
    Amersi, Farin
    Giuliano, Armando E.
    Chung, Alice
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (01) : 63 - 74
12345